From Wikipedia, the free encyclopedia
|Source||Humanized (from mouse)|
|Chemical and physical data|
|Molar mass||175.1 kg/mol|
This drug was developed by EMD Pharmaceuticals.
- Statement On A Nonproprietary Name Adopted By The Usan Council - Tucotuzumab Celmoleukin, American Medical Association.
- National Cancer Institute: Definition of tucotuzumab celmoleukin
|This monoclonal antibody-related article is a stub. You can help Wikipedia by expanding it.|
|This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it.|